组织等离子素激活剂修改型血栓凝结造影识别了免疫介导的血液溶解性贫血的狗中的纤维解质耐药性
Robert Goggs1,2, Samantha Davis3, Marjory B Brooks2
1Department of Clinical Sciences, Cornell University College of Veterinary Medicine, Ithaca, NY, United States.
Frontiers in veterinary science
|June 20, 2025
概括
患有免疫媒介血清性贫血 (IMHA) 的狗表现出纤维素分解受损,增加了血栓形成的风险. 生物标志物表明,中性粒细胞外细胞陷 (NET) 的形成导致了狗IMHA的这种危险失衡.
科学领域:
- 兽医内科 兽医内科
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 狗的免疫媒介血液溶解性贫血 (IMHA) 携带高死亡率,通常是由于血栓塞栓症.
- IMHA中的血栓形成是多因素的,涉及组织因子表达,血小板激活和中性粒细胞外细胞陷 (NET) 形成.
研究的目的:
- 为了研究IMHA的狗有纤维素分解受损的假设.
- 为了确定NET形成生物标志物是否与IMHA中的低纤维素分解有关.
主要方法:
- 20只患有IMHA的狗接受了带有和没有组织等离子素激活剂 (tPA) 的血栓电位学 (TEG) 试验.
- 血液静止试验测量了血栓激活纤维解酶抑制剂 (TAFI) 活性,等离子体激活剂抑制剂-1 (PAI-1),无细胞DNA (cfDNA) 和核细胞.
主要成果:
- 患有IMHA的狗表现出高凝血TEG,TAFI活性增加以及对纤维解质的抗性.
- 与对照犬相比,IMHA犬的cfDNA,核细胞和活性PAI-1的升高被观察到.
结论:
- 低纤维素溶解是犬类IMHA的常见特征,可能是由增加的PAI-1和TAFI驱动的.
- 在IMHA中,原血栓状况可能涉及NETosis,支持血栓预防的建议.
相关概念视频
Venous Thrombosis III: Interprofessional Care
28
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
28
Anticoagulant Drugs: Low-Molecular-Weight Heparins
924
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
924
Clot Retraction and Fibrinolysis
6.9K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.9K


